Effects of Methotrexate (MTX) treatment on cytokine profile and gene expression in Juvenile Idiopathic Arthritis (JIA)

被引:0
|
作者
Ursu, Simona [1 ]
Moncrieffe, Halima [1 ]
Kassoumeri, Laura [1 ]
Wedderburn, Lucy R. [1 ]
机构
[1] UCL Inst Child Hlth, Rheumatol Unit, London, England
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:445 / 445
页数:1
相关论文
共 50 条
  • [1] Methotrexate (MTX) Toxicity Surveillance in Juvenile Idiopathic Arthritis (JIA)
    Kocharla, Lakshmi P.
    Taylor, Janalee
    Weiler, Tracy
    Luggen, Michael
    Brunner, Hermine
    ARTHRITIS AND RHEUMATISM, 2008, 58 (12): : 3986 - 3986
  • [2] Monitoring and patient/family awareness on the use of methotrexate (MTX) in juvenile idiopathic arthritis (JIA)
    Swift, A.
    Adnan, Z.
    Abinun, M.
    Foster, H.
    RHEUMATOLOGY, 2001, 40 : 49 - 50
  • [3] Cytokine Profiles at Diagnosis of Juvenile Idiopathic Arthritis (JIA)
    Yeung, Rae
    Benseler, Susanne
    Oen, Kiem
    Tucker, Lori
    Duffy, Ciaran
    JOURNAL OF RHEUMATOLOGY, 2009, 36 (11) : 2583 - 2583
  • [4] Methotrexate for the treatment of juvenile idiopathic arthritis: process to approval for JIA indication in Japan
    Mori, Masaaki
    Naruto, Takuya
    Imagawa, Tomoyuki
    Murata, Takuji
    Takei, Syuji
    Tomiita, Minako
    Itoh, Yasuhiko
    Fujikawa, Satoshi
    Yokota, Shumpei
    MODERN RHEUMATOLOGY, 2009, 19 (01) : 1 - 11
  • [5] GENERATION OF NOVEL PHARMACOGENOMIC CANDIDATES IN THE RESPONSE TO MTX IN JUVENILE IDIOPATHIC ARTHRITIS (JIA): CORRELATION BETWEEN GENE EXPRESSION AND GENOTYPE
    Moncrieffe, Halima
    Ursu, Simona
    Jina, Nipurna
    Hinks, Anne M.
    Martin, Paul
    Thomson, Wendy
    Wedderbum, Lucy R.
    RHEUMATOLOGY, 2009, 48 : I3 - I4
  • [6] Drug Safety in Treatment of Juvenile Idiopathic Arthritis (JIA): Biologic Therapy Compared with MTX.
    Horneff, Gerd
    Huppertz, Hans
    Ganser, Gerd
    Haas, Johannes Peter
    Foeldvari, Ivan
    Minden, Kirsten
    ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S121 - S121
  • [7] GENETIC POLYMORPHISMS IN KEY METHOTREXATE (MTX) PATHWAY GENES ASSOCIATED WITH RESPONSE TO MTX TREATMENT IN JUVENILE IDIOPATHIC ARTHRITIS
    Hinks, Anne
    Moncrieffe, Halima
    Martin, Paul
    Lal, Sham D.
    Ursu, Simona
    Kassoumeri, Laura
    Wedderbum, Lucy R.
    Thomson, Wendy
    RHEUMATOLOGY, 2010, 49 : I10 - I11
  • [8] Combination of cyclosporine a and methotrexate in children with refractory juvenile idiopathic arthritis (JIA)
    Alexeieva, Y. I.
    Valieva, S. I.
    Bzarova, T. M.
    Afonina, E. Y.
    Apaeva, D. V.
    ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 : 335 - 335
  • [9] Investigating which variables from the core outcome variables in juvenile idiopathic arthritis (JIA) are the best predictors of classification as a responder to treatment with methotrexate (MTX)
    SP Hirani
    L Kassoumeri
    K Mulligan
    N Ruperto
    P Woo
    LR Wedderburn
    SP Newman
    Pediatric Rheumatology, 6 (Suppl 1)
  • [10] Methotrexate in the treatment of juvenile idiopathic arthritis
    Seeliger, S
    Niehues, T
    Harms, E
    Frosch, M
    Roth, J
    MONATSSCHRIFT KINDERHEILKUNDE, 2002, 150 (04) : 452 - 459